PMC:7534795 / 42458-42535 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T197","span":{"begin":14,"end":25},"obj":"Body_part"},{"id":"T198","span":{"begin":37,"end":45},"obj":"Body_part"}],"attributes":[{"id":"A197","pred":"fma_id","subj":"T197","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A198","pred":"fma_id","subj":"T198","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"• Use of anti-interleukin agents for cytokine storm • Phase 3 prospective RCT"}

{"project":"LitCovid-sentences","denotations":[{"id":"T330","span":{"begin":0,"end":77},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Use of anti-interleukin agents for cytokine storm • Phase 3 prospective RCT"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T157","span":{"begin":37,"end":51},"obj":"Phenotype"}],"attributes":[{"id":"A157","pred":"hp_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"• Use of anti-interleukin agents for cytokine storm • Phase 3 prospective RCT"}